Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples

Clinical Infectious Diseases

Volumn 46, Issue 8, 2008, Pages 1227-1236

  Vivekanandan, Perumal ^a   Kannangai, Rajesh ^a   Ray, Stuart C ^a   Thomas, David L ^a   Torbenson, Michael ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G;

ADULT; AGED; ARTICLE; EPIGENETICS; FEMALE; GENE DELETION; GENE ISOLATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER; MALE; METHYLATION; MOLECULAR CLONING; PRIORITY JOURNAL;

ADULT; AGED; CPG ISLANDS; CYTIDINE DEAMINASE; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DNA, VIRAL; EPIGENESIS, GENETIC; FEMALE; GENOME, VIRAL; HEPATITIS B, CHRONIC; HUMANS; LIVER; MALE; MIDDLE AGED; MUTATION;

EID: 42549090262     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/529437     Document Type: Article

References (29)

1. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis 2002;2:479-86.
2. Chan HL, Tsang SW, Leung NW, et al. Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection. Am J Gastroenterol 2002; 97:1211-5.
3. Toyoda H, Kumada T, Kiriyama S, et al. Prevalence of low-level hepatitis B viremia in patients with HBV surface antigen-negative hepatocellular carcinoma with and without hepatitis C virus infection in Japan: analysis by COBAS TaqMan Real-Time PCR. Intervirology 2007; 50:241-4.
4. Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL. High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology 2004; 39:51-7.
5. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol 2007; 46:160-70.
6. Kannangai R, Vivekanandan P, Netski D, et al. Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection. J Clin Virol 2007; 39:101-5.
7. Squadrito G, Pollicino T, Cacciola I, et al. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. Cancer 2006; 106:1326-30.
8. Hou J, Wang Z, Cheng J, et al. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 2001; 34:1027-34.
9. Kannangai R, Ray S, Torbenson M. Whole genome analysis of deletions in occult HBV. Gastroenterology 2005; 128:A744-A.
10. Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda SK. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology 2004; 127:1356-71.
11. Pollicino T, Raffa G, Costantino L, et al. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 2007; 45:277-85.
12. Hass M, Hannoun C, Kalinina T, Sommer G, Manegold C, Gunther S. Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals. Hepatology 2005; 42:93-103.
13. Vivekanandan P, Thomas D, Torbenson M. Hepatitis B is methylated in liver tissues. J Viral Hepat 2008; 15:103-7.
14. Pollicino T, Belloni L, Raffa G, et al. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology 2006; 130:823-37.
15. Noguchi C, Ishino H, Tsuge M, et al. G to A hypermutation of hepatitis B virus. Hepatology 2005; 41:626-33.
16. Turelli P, Mangeat B, Jost S, Vianin S, Trono D. Inhibition of hepatitis B virus replication by APOBEC3G. Science 2004; 303:1829.
17. Perumal V, Wang J, Thuluvath P, Choti M, Torbenson M. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum Pathol 2006; 37:1211-6.
18. Murakami Y, Saigo K, Takashima H, et al. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 2005; 54:1162-8.
19. Kannangai R, Molmenti E, Arrazola L, et al. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection. J Viral Hepat 2004; 11:297-301.
20. He ML, Wu J, Chen Y, Lin MC, Lau GK, Kung HF. A new and sensitive method for the quantification of HBV cccDNA by real-time PCR. Biochem Biophys Res Commun 2002; 295:1102-7.
21. Torbenson M, Lee JH, Choti M, et al. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway. Mod Pathol 2002; 15:189-96.
22. Schories M, Peters T, Rasenack J. Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection. J Hepatol 2000; 33:799-811.
23. Suspene R, Guetard D, Henry M, Sommer P, Wain-Hobson S, Vartanian JP. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc Natl Acad Sci USA 2005; 102:8321-6.
24. Pumpens P, Grens E, Nassal M. Molecular epidemiology and immunology of hepatitis B virus infection-an update. Intervirology 2002; 45:218-32.
25. Preikschat P, Meisel H, Will H, Gunther S. Hepatitis B virus genomes from long-term immunosuppressed virus carriers are modified by specific mutations in several regions. J Gen Virol 1999; 80(Pt 10):2685-91.
26. Oon CJ, Lim GK, Ye Z, et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 1995; 13:699-702.
27. Ahn SH, Park YN, Park JY, et al. Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. J Hepatol 2005; 42:188-94.
28. Ghisetti V, Marzano A, Zamboni F, et al. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance. Liver Transpl 2004; 10:356-62.
29. Chazouilleres O, Mamish D, Kim M, et al. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994; 343:142-6.